Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Indices of Clinical Research Coordinators' Competence.

Hornung CA, Ianni PA, Jones CT, Samuels EM, Ellingrod VL; DIAMOND Investigators.

J Clin Transl Sci. 2019 Jun;3(2-3):75-81. doi: 10.1017/cts.2019.381. Epub 2019 Jul 24.

PMID:
31552144
2.
3.

Looking for Darwin in Genomic Sequences: Validity and Success Depends on the Relationship Between Model and Data.

Jones CT, Susko E, Bielawski JP.

Methods Mol Biol. 2019;1910:399-426. doi: 10.1007/978-1-4939-9074-0_13.

PMID:
31278672
4.

Joint Task Force for Clinical Trial Competency and Clinical Research Professional Workforce Development.

Sonstein SA, Jones CT.

Front Pharmacol. 2018 Oct 16;9:1148. doi: 10.3389/fphar.2018.01148. eCollection 2018. Review.

5.

A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers.

Youngberg S, Brandt E, Barve A, Machineni S, Jones CT, Dabovic K, Jones CL, Colvin RA.

J Drug Assess. 2018 Oct 24;7(1):66-74. doi: 10.1080/21556660.2018.1535438. eCollection 2018.

6.

Leveling the Joint Task Force Core Competencies for Clinical Research Professionals.

Sonstein SA, Namenek Brower RJ, Gluck W, Kolb HR, Aldinger C, Bierer BE, Jones CT.

Ther Innov Regul Sci. 2018 Oct 18:2168479018799291. doi: 10.1177/2168479018799291. [Epub ahead of print]

PMID:
30336683
7.

The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.

Lawitz E, Bidair M, Marbury T, Jones CT, Barve A, Magnusson B, Barkan DT, Bodendorf U, Bracken K, Canino E, Chen D, Dabovic K, Heimbach T, Ison M, Jones CL, Kovacs SJ, Lakshman JP, Li B, Raman P, Steiner-Swiat R, Thohan S, Wong KA, Zhong W, Colvin RA.

Clin Ther. 2018 Sep;40(9):1567-1581.e4. doi: 10.1016/j.clinthera.2018.07.019. Epub 2018 Sep 2.

PMID:
30185394
8.

Phenomenological Load on Model Parameters Can Lead to False Biological Conclusions.

Jones CT, Youssef N, Susko E, Bielawski JP.

Mol Biol Evol. 2018 Jun 1;35(6):1473-1488. doi: 10.1093/molbev/msy049.

PMID:
29596684
9.

Interventional cardiologists: Beware and be aware: An updated report of radiation-induced cutaneous cancers.

Eagan JT Jr, Jones CT, Roubin GS.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):475-477. doi: 10.1002/ccd.27258. Epub 2017 Oct 16.

PMID:
29044964
10.

Assessment of leakage pressure following enterotomy closure reinforced by tissue adhesive in a caprine cadaver model.

Jones CT, Chen CY, Campbell BG, Fransson BA.

N Z Vet J. 2017 Sep;65(5):248-251. doi: 10.1080/00480169.2017.1344586. Epub 2017 Jul 2.

PMID:
28629261
11.

Education and training of clinical and translational study investigators and research coordinators: A competency-based approach.

Calvin-Naylor NA, Jones CT, Wartak MM, Blackwell K, Davis JM, Divecha R, Ellerbeck EF, Kieburtz K, Koziel MJ, Luzuriaga K, Maddox J, Needler NA, Murphy S, Pemberton K, Radovich C, Rubinstein EP, Selker HP, Tenaerts P, Unsworth K, Wilson K, Wright JE, Barohn R, Shanley TP.

J Clin Transl Sci. 2017 Feb;1(1):16-25. doi: 10.1017/cts.2016.2. Epub 2017 Jan 13.

12.

Shifting Balance on a Static Mutation-Selection Landscape: A Novel Scenario of Positive Selection.

Jones CT, Youssef N, Susko E, Bielawski JP.

Mol Biol Evol. 2017 Feb 1;34(2):391-407. doi: 10.1093/molbev/msw237.

PMID:
28110273
13.

Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A Inhibitor.

Owens CM, Brasher BB, Polemeropoulos A, Rhodin MH, McAllister N, Wong KA, Jones CT, Jiang L, Lin K, Or YS.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6216-26. doi: 10.1128/AAC.00815-16. Print 2016 Oct.

14.

The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production.

Scull MA, Schneider WM, Flatley BR, Hayden R, Fung C, Jones CT, van de Belt M, Penin F, Rice CM.

PLoS Pathog. 2015 Nov 20;11(11):e1005297. doi: 10.1371/journal.ppat.1005297. eCollection 2015 Nov.

15.

Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response.

Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14554. Epub 2015 Jul 8. No abstract available.

PMID:
26153858
16.

Research nurse manager perceptions about research activities performed by non-nurse clinical research coordinators.

Jones CT, Hastings C, Wilson LL.

Nurs Outlook. 2015 Jul-Aug;63(4):474-83. doi: 10.1016/j.outlook.2015.02.002. Epub 2015 Feb 14.

PMID:
26081563
17.

V3 interneuron subpopulations in the mouse spinal cord undergo distinctive postnatal maturation processes.

Borowska J, Jones CT, Deska-Gauthier D, Zhang Y.

Neuroscience. 2015 Jun 4;295:221-8. doi: 10.1016/j.neuroscience.2015.03.024. Epub 2015 Mar 21.

PMID:
25800308
18.

Sim1 is required for the migration and axonal projections of V3 interneurons in the developing mouse spinal cord.

Blacklaws J, Deska-Gauthier D, Jones CT, Petracca YL, Liu M, Zhang H, Fawcett JP, Glover JC, Lanuza GM, Zhang Y.

Dev Neurobiol. 2015 Sep;75(9):1003-17. doi: 10.1002/dneu.22266. Epub 2015 Feb 18.

19.

Optimizing anticonvulsant administration for children before anesthesia: a quality improvement project.

Jones CT, Raman VT, DeVries S, Cole JW, Kelleher KJ, Tobias JD.

Pediatr Neurol. 2014 Nov;51(5):632-40. doi: 10.1016/j.pediatrneurol.2014.07.029. Epub 2014 Jul 30.

PMID:
25193412
20.

Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.

Barnes-Seeman D, Boiselle C, Capacci-Daniel C, Chopra R, Hoffmaster K, Jones CT, Kato M, Lin K, Ma S, Pan G, Shu L, Wang J, Whiteman L, Xu M, Zheng R, Fu J.

Bioorg Med Chem Lett. 2014 Aug 15;24(16):3979-85. doi: 10.1016/j.bmcl.2014.06.031. Epub 2014 Jun 20.

PMID:
24986660
21.

Curvature in models of the photosynthesis-irradiance response.

Jones CT, Craig SE, Barnett AB, MacIntyre HL, Cullen JJ.

J Phycol. 2014 Apr;50(2):341-55. doi: 10.1111/jpy.12164. Epub 2014 Mar 7.

PMID:
26988191
22.

Functional subpopulations of V3 interneurons in the mature mouse spinal cord.

Borowska J, Jones CT, Zhang H, Blacklaws J, Goulding M, Zhang Y.

J Neurosci. 2013 Nov 20;33(47):18553-65. doi: 10.1523/JNEUROSCI.2005-13.2013.

23.

Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Catanese MT, Loureiro J, Jones CT, Dorner M, von Hahn T, Rice CM.

J Virol. 2013 Aug;87(15):8282-93. doi: 10.1128/JVI.01102-13. Epub 2013 May 22.

24.

Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals.

Kim HY, Li X, Jones CT, Rice CM, Garcia JM, Genovesio A, Hansen MA, Windisch MP.

Antiviral Res. 2013 Jul;99(1):6-11. doi: 10.1016/j.antiviral.2013.04.020. Epub 2013 May 6.

25.

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.

Law JL, Chen C, Wong J, Hockman D, Santer DM, Frey SE, Belshe RB, Wakita T, Bukh J, Jones CT, Rice CM, Abrignani S, Tyrrell DL, Houghton M.

PLoS One. 2013;8(3):e59776. doi: 10.1371/journal.pone.0059776. Epub 2013 Mar 19.

26.

Enhancing research capacity for global health: evaluation of a distance-based program for international study coordinators.

Wilson LL, Rice M, Jones CT, Joiner C, LaBorde J, McCall K, Jester PM, Carter SC, Boone C, Onwuzuligbo U, Koneru A.

J Contin Educ Health Prof. 2013 Winter;33(1):67-75. doi: 10.1002/chp.21167.

27.

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells.

Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM.

Hepatology. 2011 Dec;54(6):1901-12. doi: 10.1002/hep.24557.

28.

A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Meuleman P, Catanese MT, Verhoye L, Desombere I, Farhoudi A, Jones CT, Sheahan T, Grzyb K, Cortese R, Rice CM, Leroux-Roels G, Nicosia A.

Hepatology. 2012 Feb;55(2):364-72. doi: 10.1002/hep.24692. Epub 2011 Dec 16.

29.

Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures.

Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB.

Hepatology. 2011 Dec;54(6):1913-23. doi: 10.1002/hep.24580.

30.

A genetically humanized mouse model for hepatitis C virus infection.

Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A.

Nature. 2011 Jun 8;474(7350):208-11. doi: 10.1038/nature10168.

31.

A diverse range of gene products are effectors of the type I interferon antiviral response.

Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM.

Nature. 2011 Apr 28;472(7344):481-5. doi: 10.1038/nature09907. Epub 2011 Apr 10. Erratum in: Nature. 2015 Sep 3;525(7567):144.

32.

Cutaneous cancers in an interventional cardiologist: a cautionary tale.

Eagan JT Jr, Jones CT.

J Interv Cardiol. 2011 Feb;24(1):49-55. doi: 10.1111/j.1540-8183.2010.00610.x. Epub 2010 Nov 28.

PMID:
21114530
33.

Advances and challenges in studying hepatitis C virus in its native environment.

Sheahan T, Jones CT, Ploss A.

Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):541-50. doi: 10.1586/egh.10.53. Review.

PMID:
20932139
34.

Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions.

Law LM, Albin OR, Carroll JW, Jones CT, Rice CM, Macdonald MR.

J Virol. 2010 May;84(9):4504-12. doi: 10.1128/JVI.02018-09. Epub 2010 Feb 24.

35.

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.

Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, Gaysinskaya VA, Mu K, Ritola K, Rice CM, Bhatia SN.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3141-5. doi: 10.1073/pnas.0915130107. Epub 2010 Feb 1.

36.

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.

Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM.

Nat Biotechnol. 2010 Feb;28(2):167-71. doi: 10.1038/nbt.1604. Epub 2010 Jan 31.

37.

Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein.

Kopp M, Murray CL, Jones CT, Rice CM.

J Virol. 2010 Feb;84(4):1666-73. doi: 10.1128/JVI.02043-09. Epub 2009 Dec 9.

38.

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB.

Hepatology. 2008 Dec;48(6):1843-50. doi: 10.1002/hep.22550.

39.

Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis.

Murray CL, Jones CT, Rice CM.

Nat Rev Microbiol. 2008 Sep;6(9):699-708. doi: 10.1038/nrmicro1928. Review.

40.
41.

Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus.

Murray CL, Jones CT, Tassello J, Rice CM.

J Virol. 2007 Oct;81(19):10220-31. Epub 2007 Jul 18.

42.

Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.

Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM.

J Virol. 2007 Aug;81(16):8374-83. Epub 2007 May 30.

43.

Functional requirements of the yellow fever virus capsid protein.

Patkar CG, Jones CT, Chang YH, Warrier R, Kuhn RJ.

J Virol. 2007 Jun;81(12):6471-81. Erratum in: J Virol. 2007 Dec;81(24):13944.

44.

Superinfection exclusion in cells infected with hepatitis C virus.

Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM.

J Virol. 2007 Apr;81(8):3693-703. Epub 2007 Feb 7.

45.

The effect of exercise on outcomes for hospitalised older acute medical patients: an individual patient data meta-analysis.

De Morton NA, Jones CT, Keating JL, Berlowitz DJ, MacGregor L, Lim WK, Jackson B, Brand CA.

Age Ageing. 2007 Mar;36(2):219-22. Epub 2006 Dec 20. No abstract available.

PMID:
17182667
46.

The fabrication and use of an extraoral surgical guide for implant placement coincident with soft tissue matrix expansion grafts: a clinical report.

Kudyba PS Jr, Loetscher CA, Perciaccante VJ, Jones CT, Cantrell JH.

J Prosthet Dent. 2006 Oct;96(4):227-32.

PMID:
17052465
47.

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA.

J Virol. 2006 Nov;80(22):11331-42. Epub 2006 Aug 30.

48.
49.

Microtensile bond strength testing and failure analysis of hybrid and flowable composites.

Jones CT, Chan DC, Pashley D, de Goes MF, Nelson SK.

J Adhes Dent. 2006 Feb;8(1):13-20.

PMID:
16536339
50.

Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM.

J Virol. 2006 Feb;80(4):1734-41.

Supplemental Content

Loading ...
Support Center